A standardized, evidence-based protocol to assess clinical actionability of genetic disorders associated with genomic variation-Reference-Cited by-同舟云学术

A standardized, evidence-based protocol to assess clinical actionability of genetic disorders associated with genomic variation

Published:2016-12 Issue:12 Volume:18 Page:1258-1268
ISSN:1098-3600
Container-title:Genetics in Medicine
language:en
Short-container-title:Genetics in Medicine

Author:

Hunter Jessica Ezzell^ORCID,Irving Stephanie A.,Biesecker Leslie G.,Buchanan Adam^ORCID,Jensen Brian,Lee Kristy^ORCID,Martin Christa Lese,Milko Laura,Muessig Kristin^ORCID,Niehaus Annie D.^ORCID,O’Daniel Julianne^ORCID,Piper Margaret A.^ORCID,Ramos Erin M.,Schully Sheri D.^ORCID,Scott Alan F.,Slavotinek Anne,Sobreira Nara,Strande Natasha,Weaver Meredith,Webber Elizabeth M.^ORCID,Williams Marc S.^ORCID,Berg Jonathan S.^ORCID,Evans James P.^ORCID,Goddard Katrina A.B.^ORCID

Publisher

Elsevier BV

Subject

Genetics (clinical)

Link

http://www.nature.com/articles/gim201640.pdf

Reference23 articles.

1. Presidential Commission for the Study of Bioethical Issues. Anticipate and Communicate: Ethical Management of Incidental and Secondary Findings in the Clinical, Research, and Direct-to-Consumer Contexts. Presidential Commission for the Study of Bioethical Issues: Washington, DC, 2013.

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design and pilot results from the Million Veteran Program Return Of Actionable Results (MVP-ROAR) Study;American Heart Journal;2024-10

2. Evaluating whole genome sequencing for rare diseases in newborn screening: evidence synthesis from a series of systematic reviews;2024-09-04

3. Multigenic panels in breast cancer: Clinical utility and management of patients with pathogenic variants other than BRCA1/2;Critical Reviews in Oncology/Hematology;2024-09

4. Breaching Confidentiality in Genetic and Non-Genetic Cases: Two Problematic Distinctions;The American Journal of Bioethics;2024-08-20

5. Implementing evidence-based assertions of clinical actionability in the context of secondary findings: Updates from the ClinGen Actionability Working Group;Genetics in Medicine;2024-08